GENE ONLINE|News &
Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
Several start-up companies have been actively engaged in this flourishing field of drug research and development in recent years. They have successively gained the breakthrough therapy designation from the FDA or carried out IPOs. The following are four notable biotechnology companies around the world: Compass Pathways, Atai Life Sciences, MindMed, and Cybin.
It's free! Log in now to read
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
